ETON
Price:
$8.35
Market Cap:
$215.73M
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in c...[Read more]
Industry
Biotechnology
IPO Date
2018-11-13
Stock Exchange
NASDAQ
Ticker
ETON
According to Eton Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Eton Pharmaceuticals, Inc. over the last ten years is 0.38%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), ETON's Dividend Yield was at its highest in in the December 2018 quarter at 1.47%. The Dividend Yield was at its lowest in in the June 2017 quarter at 0%.
Average
0.38%
Median
0%
Minimum
0%
Maximum
2.67%
Discovering the peaks and valleys of Eton Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 2.67%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | -100.00% |
2018 | 2.67% | Infinity% |
The current Dividend Yield of Eton Pharmaceuticals, Inc. (ETON) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0.38%
Eton Pharmaceuticals, Inc.’s Dividend Yield is less than Connect Biopharma Holdings Limited (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than Nuvation Bio Inc. (0%), less than Eledon Pharmaceuticals, Inc. (0%), less than Eliem Therapeutics, Inc. (0%), less than Inhibrx Biosciences, Inc. (5.47%), less than Merrimack Pharmaceuticals, Inc. (99.70%), less than Celcuity Inc. (0%), less than Enliven Therapeutics, Inc. (0%), less than Replimune Group, Inc. (0%), less than Nuvectis Pharma, Inc. (0%), less than Lyra Therapeutics, Inc. (0%), less than Kronos Bio, Inc. (0%), less than Gossamer Bio, Inc. (0%), less than Tarsus Pharmaceuticals, Inc. (0%), less than LianBio (3.01%), less than Aldeyra Therapeutics, Inc. (0%), less than Travere Therapeutics, Inc. (0%), less than Passage Bio, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than TCR2 Therapeutics Inc. (0%), less than Harpoon Therapeutics, Inc. (0%), less than Alector, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $66.30M | |
0% | $177.24M | |
0% | $764.36M | |
0% | $280.20M | |
0% | $342.68M | |
5.47% | $225.10M | |
99.70% | $223.97M | |
0% | $568.78M | |
0% | $1.31B | |
0% | $821.22M | |
0% | $117.70M | |
0% | $17.21M | |
0% | $57.28M | |
0% | $200.50M | |
0% | $1.76B | |
3.01% | $34.47M | |
0% | $307.80M | |
0% | $1.41B | |
0% | $37.34M | |
0% | $168.95M | |
0% | $58.11M | |
0% | $865.08M | |
0% | $512.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eton Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eton Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Eton Pharmaceuticals, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Eton Pharmaceuticals, Inc. (ETON)?
What is the highest Dividend Yield for Eton Pharmaceuticals, Inc. (ETON)?
What is the 3-year average Dividend Yield for Eton Pharmaceuticals, Inc. (ETON)?
What is the 5-year average Dividend Yield for Eton Pharmaceuticals, Inc. (ETON)?
How does the current Dividend Yield for Eton Pharmaceuticals, Inc. (ETON) compare to its historical average?